Related Experiment Video
Updated: Nov 22, 2025

08:52
Chemical Dimerization-Induced Protein Condensates on Telomeres
Published on: April 12, 2021
3.4K
Biomolecular Condensates and Cancer
Ann Boija1, Isaac A Klein2, Richard A Young3
1Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Cancer Cell
|January 8, 2021
Summary
Biomolecular condensates, membrane-less cellular compartments, are increasingly linked to cancer development and progression. Understanding these structures offers new therapeutic strategies for cancer treatment.
Area of Science:
- Cell Biology
- Biochemistry
- Cancer Research
Background:
- Malignant transformation involves dysregulated cellular processes, increasingly understood to occur within biomolecular condensates.
- Biomolecular condensates are membrane-less organelles formed via liquid-liquid phase separation, compartmentalizing functional protein and RNA molecules.
Purpose of the Study:
- To summarize key features of biomolecular condensates.
- To highlight their role in oncogenesis and cancer therapeutics.
- To identify future research directions.
Main Methods:
- Literature review and synthesis of current research on biomolecular condensates in cancer.
- Analysis of implicated cellular processes and their relation to condensate formation.
- Evaluation of condensate influence on cancer drug pharmacodynamics.
Main Results:
- Biomolecular condensates play a significant role in cellular dysregulation during cancer.
- Condensates are implicated in various stages of oncogenesis.
- The behavior of cancer therapeutics is demonstrably influenced by condensate properties.
Conclusions:
- Biomolecular condensates represent a paradigm shift in understanding cancer biology.
- Targeting condensate formation or function may offer novel therapeutic avenues.
- Further research is crucial to fully elucidate and exploit the role of condensates in cancer treatment.
Related Concept Videos
What is Cancer?
12.7K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
12.7K
Adaptive Mechanisms in Cancer Cells
6.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.2K
Combination Therapies and Personalized Medicine
5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Metastasis
6.1K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.1K
Condensins
4.2K
Condensins are large protein complexes that use ATP to fuel the assembly of chromosomes during mitosis. They transform the tangled, shapeless mass of post-interphase DNA into individualized chromosomes by compacting, organizing, and segregating chromosomal DNA.
The plant and animal cells contain two types of condensin complexes—condensin I and condensin II. Both complexes have five subunits: two SMC (Structural Maintenance of Chromosomes) subunits, a kleisin subunit, and two HEAT-repeat...
The plant and animal cells contain two types of condensin complexes—condensin I and condensin II. Both complexes have five subunits: two SMC (Structural Maintenance of Chromosomes) subunits, a kleisin subunit, and two HEAT-repeat...
4.2K
Cancer Therapies
9.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.1K

